CRISPR Epigenome Editing Identifies Regulatory Elements of Human Cells

Abby Olena, The Scientist 3 April 2017

Determining the function of non-protein coding DNA has traditionally been a difficult task despite its regulatory role and implication in diseases such as cardiovascular, diabetes, and neurological disorders.  By using dCas9 researchers could create a repressor form of dCas9 that facilitates methylation of histone H3 and an activator form of dCas9 which facilitates the acetylation of histone H3.  These two forms of dCas9 allow for rapid screening of gene expression levels resulting from targeted changes in the epigenome.  This research has been published in Nature Biotechnology (

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply